PPARG and neoplasm: Althoughthe antiproliferative effects of PPARγ appear to be lost in cells that have eithergerm line or somatic mutations in β-catenin signaling, the data indicate that thisreceptor still retains the ability to inhibit tumor progression, at least inAOM-induced tumors.